Abstract
This work exemplifies a general method of studying the drug excipient interactions, with the aim of predicting rapidly and inexpensively the long term stability of their mixtures. We study the physico-chemical properties of a drug (indomethacin) in the solid state and in different combinations with several excipients (PVP=polyvinylpyrrolidone, MGST=magnesium stearate, Avicel©). We compare the properties of pure compounds (untreated, or moisture/temperature conditioned) with those of binary mixtures drug:excipient which underwent the same treatment. The purpose is to find indications of interactions within the mixtures, which means a potential incompatibility of the excipient. Both morphological and thermal properties are sensitive to interactions which leave mostly unmodified the IR spectra and the X-rays patterns. In particular, we find that indomethacin does interact with PVP and MGST, but is certainly compatible with Avicel©.
Similar content being viewed by others
References
G. N. Kalinkova, Int. J. Pharm., 187 (1999) 1.
T. Dürig and A. R. Fassihi, Int. J. Pharm., 97 (1993) 161.
D. C. Monkhouse, Drug Dev. Ind. Pharm., 10 (1984) 1373.
A. R. Fassihi and P. H. R. Persicaner, Int. J. Pharm., 37 (1987) 167.
J. T. Carstensen, J. Pharm. Sci., 63 (1974) 1.
J. T. Carstensen, Drug Dev. Ind. Pharm., 14 (1988) 1927.
D. C. Monkhouse and A. Maderich, Drug Dev. Ind. Pharm., 15 (1989) 2115.
S. A. Botha, A. P. Lötter and J. L. du Preez, Drug Dev. Ind. Pharm., 13 (1987) 1197.
A. T. M. Serajuddin, A. B. Thakur, R. N. Ghoshal, M. G. Fakes, S. A. Ranadive, K. R. Morris and S. A. Varia, J. Pharm. Sci., 88 (1999) 696.
J. G. Kesevan and G. E. Peck, Drug Dev. Ind. Pharm., 22 (1996) 189.
H. Nyqvist and P. Lundgren, Acta Pharm. Suec., 19 (1982) 401.
Y. Matsunaga, R. Ohta, N. Bando, H. Yamada, H. Yuasa and Y. Kanaya, Chem. Pharm. Bull., 41 (1993) 720.
C. Ahlneck and G. Zografi, Int. J. Pharm., 62 (1990) 87.
J. T. Carstensen, M. Osadca and S. H. Rubin, J. Pharm. Sci., 58 (1969) 549.
E. De Ritter, L. Magid, M. Osadca and S. H. Rubin, J. Pharm. Sci., 59 (1970) 229.
S. Yoshioka and M. Uchiyama, J. Pharm. Sci., 75 (1986) 459.
J. O. Waltersson, Acta Pharm. Suec., 23 (1986) 129.
N. R. Bohidar, F. A. Restaino and J. B. Schwartz, Drug Dev. Ind. Pharm., 5 (1979) 175.
G. Bruni, L. Amici, V. Berbenni, A. Marini and A. Orlandi, J. Therm. Anal. Cal., 68 (2002) 561.
D. Giron and C. Goldbronn, J. Therm. Anal. Cal., 48 (1997) 473.
M. O'Brien, J. McCauley and E. Cohen, Analytical profile of drug substances, Klaus Florey, Academic Press 1984, p. 211.
D. J. Allen and K. C. Kwan, J. Pharm. Sci., 58 (1969) 1190.
D. C. Monkhouse and J. L. Lach, J. Pharm. Sci., 61 (1972) 1435.
H. Yamamoto, Chem. Pharm. Bull., 16 (1968) 17.
L. Borka, Acta Pharm. Suec., 11 (1974) 295.
S. Y. Lin and J. Y. Cherng, J. Thermal Anal., 45 (1995) 1565.
S. Y. Lin and Y. H. Kao, J. Thermal Anal., 36 (1990) 2493.
R. O. Macedo, T. G. Do Nascimento and J. W. E. Veras, J. Therm. Anal. Cal., 67 (2002) 483.
M. E. Brown, E. M. Antunes, B. D. Glass, M. Lebete and R. B. Walker, J. Therm. Anal. Cal., 56 (1999) 1317.
F. Giordano, A. Rossi, R. Bettini, A. Ravioli, A. Gazzaniga and Cs. Novak, J. Therm. Anal. Cal., 68 (2002) 575.
R. O. Macedo, T. G. Do Nascimento and J. W. E. Veras, J. Therm. Anal. Cal., 64 (2001) 757.
K. D. Ertel and J. T. Carstensen, Int. J. Pharm., 42 (1988) 171.
K. D. Ertel and J. T. Carstensen, J. Pharm. Sci., 77 (1988) 625.
P. V. Mroso, A. Li Wan Po and W. J. Irwin, J. Pharm. Sci., 71 (1982) 1096.
S. A. Sharpe, M. Celik, A. W. Newman and H. G. Brittain, Struct. Chem., 8 (1997) 73.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marini, A., Berbenni, V., Moioli, S. et al. Drug-excipient compatibility studies by physico-chemical techniques; The case of Indomethacin. Journal of Thermal Analysis and Calorimetry 73, 529–545 (2003). https://doi.org/10.1023/A:1025426012578
Issue Date:
DOI: https://doi.org/10.1023/A:1025426012578